The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
Open accessAbstract
Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4+ T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon gamma- or IL-4-induced, class II MHC expression on monocytes by IL-10 and v-IL-10, resulting in the reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen-presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed IL-1 alpha, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen-specific responses were observed in the presence of neutralizing anti-IL-1, -IL-6, and -TNF-alpha mAbs. Furthermore, addition of saturating concentrations of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha to the cultures had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Expression and secretion of type beta transforming growth factor by activated human macrophages.
Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6020 · Cited by 970
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
Self-citationStructure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
Hsu, D.-H., Malefyt, R. D. W., Fiorentino, D. F., Dang, M.-N., Vieira, P., deVries, J., Spits, H., Mosmann, T. R., & Moore, K. W. (1990) · Science · doi:10.1126/science.2173142 · Cited by 535
Self-citationSimultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard, X., de Waal Malefijt, R., Yssel, H., Blanchard, D., Chrétien, I., Abrams, J., de Vries, J., & Spits, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.849 · Cited by 512
Self-citationInterleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
Scheurich, P., Thoma, B., Ucer, U., & Pfizenmaier, K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1786 · Cited by 492
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Self-citationIsolation and characterization of antigen-la complexes involved in T cell recognition
Buus, S., Sette, A., Colon, S. M., Jenis, D. M., & Grey, H. M. (1986) · Cell · doi:10.1016/0092-8674(86)90822-6 · Cited by 467
Harding, C. V., & Unanue, E. R. (1990) · Nature · doi:10.1038/346574a0 · Cited by 453
te Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Self-citationThe biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route
Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J., & Ploegh, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90224-3 · Cited by 439
A new murine CD4+ T cell subset with an unrestricted cytokine profile.
Firestein, G. S., Roeder, W. D., Laxer, J. A., Townsend, K. S., Weaver, C. T., Hom, J. T., Linton, J., Torbett, B. E., & Glasebrook, A. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.2.518 · Cited by 361
IL-10, a novel growth cofactor for mature and immature T cells.
MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbls, D., Stall, A., Cupp, J., Moore, K., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344
Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes
Braciale, T. J., Morrison, L. A., Sweetser, M. T., Sambrook, J., Gething, M., & Braciale, V. L. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00521.x · Cited by 320
Shimizu, Y., Van Seventer, G. A., Horgan, K. J., & Shaw, S. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00563.x · Cited by 316
Selection of a human T helper type 1-like T cell subset by mycobacteria.
Haanen, J. B., de Waal Malefijt, R., Res, P. C., Kraakman, E. M., Ottenhoff, T. H., de Vries, R. R., & Spits, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.583 · Cited by 279
Self-citationThe Interaction between Protein‐Derived Immunogenic Peptides and Ia
Buus, S., Sette, A., & Grey, H. M. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00522.x · Cited by 198
Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes.
Tosato, G., & Pike, S. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.5.1556 · Cited by 122
Ottenhoff, T. H. M., & Mutis, T. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.6.2011 · Cited by 93
A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistry
Koning, F., Schreuder, I., Giphart, M. J., & Bruning, H. W. (1984) · Human Immunology · doi:10.1016/0198-8859(84)90027-2 · Cited by 92
Harding, C. V., Unanue, E. R., Slot, J. W., Schwartz, A. L., & Geuze, H. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5553 · Cited by 80
Davis, J. E., & Cresswell, P. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.3.990 · Cited by 64
A centrifugal elutriation system of separating small numbers of cells
Figdor, C. G., Es, W. L. V., Leemans, J., & Bont, W. S. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90138-8 · Cited by 24
Self-citation
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Self-citationThe Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Metadata
- Authors
- de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-10-01
- Volume
- 174
- Issue
- 4
- Pages
- 915-924
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2101771134
- Cited by
- 1,930
- References
- 28
- FWCI
- 25.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.